Gamma-aminobutyric acid and the search for new anticonvulsant drugs.
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000445:Aldehyde Oxidoreductases / Q000037:antagonists & inhibitors; D000613:Aminobutyrates / Q000627:therapeutic use*; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D001418:Baclofen / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D000882:Haplorhini; D006801:Humans; D051379:Mice; D009207:Myoclonus / Q000188:drug therapy; D010215:Papio; D011760:Pyrrolidinones / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use*
D000613:Aminobutyrates; D000927:Anticonvulsants; D001570:Benzodiazepinones; D011760:Pyrrolidinones; D005680:gamma-Aminobutyric Acid; D000445:Aldehyde Oxidoreductases; D000612:4-Aminobutyrate Transaminase; D001418:Baclofen